1. Home
  2. UTMD vs KROS Comparison

UTMD vs KROS Comparison

Compare UTMD & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utah Medical Products Inc.

UTMD

Utah Medical Products Inc.

HOLD

Current Price

$74.20

Market Cap

231.7M

Sector

Health Care

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.21

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTMD
KROS
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.7M
206.0M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UTMD
KROS
Price
$74.20
$11.21
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$21.86
AVG Volume (30 Days)
22.0K
156.2K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
146.00
EPS
1.66
N/A
Revenue
$38,520,000.00
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,751.79
P/E Ratio
$44.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$53.66
$9.69
52 Week High
$75.75
$22.55

Technical Indicators

Market Signals
Indicator
UTMD
KROS
Relative Strength Index (RSI) 61.66 52.28
Support Level $68.77 $10.57
Resistance Level $75.38 $11.61
Average True Range (ATR) 1.47 0.41
MACD 0.38 -0.02
Stochastic Oscillator 86.09 42.86

Price Performance

Historical Comparison
UTMD
KROS

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: